Conversion Efficacy and Safety of Intravenous Ibutilide Compared With Intravenous Procainamide in Patients With Atrial Flutter or Fibrillation 11This study was sponsored by Pharmacia & Upjohn, Kalamazoo, Michigan.22See Appendix Afor a complete list of investigators and study sites.

This publication has 12 references indexed in Scilit:

• Safety and Risk/Benefit Analysis of Ibutilide for Acute Conversion of Atrial Fibrillation/Flutter
  The American Journal of Cardiology, 1996
• Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation
  Circulation, 1996
• Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study
  Journal of the American College of Cardiology, 1996
• Effect of Ibutilide, a New Class III Agent, On Sustained Atrial Fibrillation in a Canine Model of Acute Ischemia and Myocardial Dysfunction Induced By Microembolization
  Pacing and Clinical Electrophysiology, 1993
• Antiarrhythmic and Electrophysiologic Effects of Ibutilide in a Chronic Canine Model of Atrial Flutter
  Journal of Cardiovascular Pharmacology, 1993
• Membrane activity of class III antiarrhythmic compounds; a comparison between ibutilide, d-sotalol, E-4031, sematilide and dofetilide
  European Journal of Pharmacology, 1993
• Effects of ibutilide fumarate, a novel antiarrhythmic agent, and its enantiomers on isolated rabbit myocardium
  European Journal of Pharmacology, 1992
• Effects of Ibutilide on Spontaneous and Induced Ventricular Arrhythmias in 24-Hour Canine Myocardial Infarction
  Journal of Cardiovascular Pharmacology, 1992
• Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion
  American Heart Journal, 1983
• Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm. Relation to left atrial size.
  Heart, 1980